In severely immunodeficient NSG mice bearing subcutaneous KPC PDAC tumors, treatment with the DDR1-neutralizing antibody alone did not significantly inhibit tumor growth compared to human IgG1-Fc controls (Figure 9A). The gene discussed is DDR1; the disease is neoplasm.